NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,437,074 | +2.7% | 2,468,110 | +35.8% | 0.58% | +13.8% |
| Q2 2023 | $46,192,944 | -4.1% | 1,817,189 | +36.5% | 0.51% | -7.3% |
| Q1 2023 | $48,142,979 | -2.9% | 1,331,756 | +6.4% | 0.55% | -7.6% |
| Q4 2022 | $49,587,833 | -7.6% | 1,252,218 | +8.8% | 0.59% | -10.0% |
| Q3 2022 | $53,639,000 | +5.3% | 1,151,060 | -0.9% | 0.66% | +12.9% |
| Q2 2022 | $50,931,000 | -17.7% | 1,162,013 | +35.8% | 0.58% | +7.8% |
| Q1 2022 | $61,874,000 | +2.8% | 855,439 | +15.2% | 0.54% | +12.2% |
| Q4 2021 | $60,181,000 | +19.1% | 742,332 | +70.9% | 0.48% | +22.0% |
| Q3 2021 | $50,551,000 | -19.8% | 434,359 | +14.3% | 0.40% | -16.7% |
| Q2 2021 | $63,010,000 | +55.9% | 380,057 | +31.2% | 0.47% | +57.0% |
| Q1 2021 | $40,415,000 | -22.9% | 289,710 | -4.4% | 0.30% | -25.6% |
| Q4 2020 | $52,431,000 | +10.4% | 302,894 | -11.2% | 0.41% | -10.4% |
| Q3 2020 | $47,501,000 | -6.5% | 341,001 | -19.8% | 0.45% | -13.7% |
| Q2 2020 | $50,789,000 | +10.2% | 425,123 | -7.8% | 0.52% | -13.2% |
| Q1 2020 | $46,080,000 | -31.7% | 460,895 | -19.7% | 0.60% | +0.8% |
| Q4 2019 | $67,471,000 | +30.5% | 574,026 | -4.6% | 0.60% | +16.3% |
| Q3 2019 | $51,711,000 | -13.9% | 601,503 | -35.1% | 0.52% | -10.7% |
| Q2 2019 | $60,082,000 | -48.9% | 926,756 | -50.8% | 0.58% | -47.9% |
| Q1 2019 | $117,644,000 | +69.3% | 1,882,009 | +5.3% | 1.11% | +52.1% |
| Q4 2018 | $69,478,000 | -2.0% | 1,786,523 | +43.6% | 0.73% | +22.7% |
| Q3 2018 | $70,927,000 | -6.1% | 1,244,340 | +31.5% | 0.59% | -14.3% |
| Q2 2018 | $75,537,000 | +14.3% | 945,992 | +24.0% | 0.69% | +4.8% |
| Q1 2018 | $66,112,000 | +25.5% | 762,799 | -0.0% | 0.66% | +24.0% |
| Q4 2017 | $52,673,000 | -24.1% | 762,929 | -0.1% | 0.53% | -32.4% |
| Q3 2017 | $69,424,000 | +28.4% | 763,912 | +5.1% | 0.79% | +17.8% |
| Q2 2017 | $54,077,000 | +69.1% | 726,549 | +112.9% | 0.67% | +53.7% |
| Q1 2017 | $31,976,000 | +1.3% | 341,263 | -21.4% | 0.44% | -12.6% |
| Q4 2016 | $31,556,000 | +22.0% | 434,302 | +75.2% | 0.50% | +6.2% |
| Q3 2016 | $25,870,000 | +16.9% | 247,821 | -17.4% | 0.47% | +4.9% |
| Q2 2016 | $22,125,000 | -2.1% | 299,965 | -25.3% | 0.45% | -10.8% |
| Q1 2016 | $22,598,000 | +759.2% | 401,669 | +608.6% | 0.50% | +597.2% |
| Q3 2015 | $2,630,000 | +1.7% | 56,687 | +17.8% | 0.07% | +14.3% |
| Q2 2015 | $2,587,000 | +84.0% | 48,139 | +64.1% | 0.06% | +75.0% |
| Q1 2015 | $1,406,000 | +42.5% | 29,333 | +14.9% | 0.04% | +44.0% |
| Q4 2014 | $987,000 | – | 25,528 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |